---
ID: P89
Title: Patient-Reported Outcomes & Quality of Life
Registry: CLAI-OS Human Good Systems (P-series)
License: Open documentation release (prompt body withheld for validation)
Version: 1.0.0
Author: Dr. Christabel Odeta — SAVANT FRAMEWORK · CLAI-OS · AEGIS-GLOBAL
Last Updated: 2026-10-12
---

# P89: Patient-Reported Outcomes & Quality of Life

## Abstract

Laboratory normalization and radiographic response do not necessarily correspond to patient wellbeing, survivorship functionality, or meaningful recovery. P89 operationalizes lived experience, symptom burden, functional capacity, psychosocial distress, and quality-of-life trajectories as primary clinical data streams, recognizing the patient as the only authoritative source on pain, fatigue, emotional suffering, functional decline, and treatment burden.

> Prompt body: WITHHELD. This is an open documentation release — abstract, methodology, and merits — published so the design can be examined and validated.

## Methodology

### Clinical Logic

- Adaptive patient-reported outcome collection via PROMIS computer-adaptive testing, ESAS, FACT-G, EORTC QLQ-C30, EQ-5D, and disease-specific instruments, minimizing burden to roughly five to seven questions per domain.
- Longitudinal symptom surveillance tracking pain, fatigue, dyspnea, sleep disturbance, anxiety, depression, cognitive dysfunction, appetite, nausea, social participation, sexual function, and functional independence with automated escalation triggers.
- Quality-adjusted survival modeling (QALY, Q-TWiST, symptom-free survival, functional independence duration, toxicity-adjusted survival) supporting therapy comparisons beyond raw survival.
- Treatment burden analytics evaluating travel burden, financial toxicity, appointment overload, medication complexity, caregiver strain, work disruption, and social isolation for treatment adaptation and de-escalation planning.
- Patient-prioritized outcome alignment capturing goals of care, values hierarchy, symptom priorities, functional goals, and tradeoff tolerance, such as prioritizing cognition over survival extension.

### Safety Posture

- Patient-Authoritative Data Architecture elevates patient-reported data to a primary clinical stream rather than secondary anecdote, with automatic treatment modification review when quality-of-life decline exceeds therapeutic benefit.
- Remote Monitoring Infrastructure supports smartphone surveys, SMS check-ins, wearable integrations, voice symptom reporting, and caregiver-assisted reports, with automated escalation for severe symptom thresholds, suicidal ideation, or functional collapse.
- Equity-Accessible PRO provides low-literacy interfaces, multilingual reporting, disability-adapted reporting, offline synchronization, and rural mobile integration to prevent digital exclusion bias.

### Integration Points

- **Upstream:** P73 (Palliative Navigator) for end-of-life PRO integration; P79 (Pain Management) for analgesic outcome validation.
- **Downstream:** P90 (Health System Resilience) for population quality analytics; P109 (Health Economics) for value-based care optimization.

Like all Tier II modules, this module shares the common CLAI-OS methodological substrate: deterministic safety compilation, context-sensitive adaptation, closed-loop accountability, federated learning via encrypted gradients rather than raw data, and graceful degradation under bandwidth, power, staffing, and infrastructure failure.

## Merits

- Corrects the documented gap between clinical response markers and lived recovery by making patient report a primary data stream with escalation force.
- Proposed validation metrics: symptom control adequacy by patient report, treatment toxicity blindness reduction, supportive care referral timing, quality-of-life trajectory preservation, patient engagement rate, caregiver burnout visibility, and survivorship neglect reduction.
- Designed against digital exclusion: low-literacy, multilingual, disability-adapted, and offline-capable collection is specified as a requirement, not an enhancement.

The merits above are design-level statements drawn from the published abstract and methodology. No peer-reviewed outcome evaluations accompany this release; the listed indicators are the metrics the design proposes for validation. Status: partial documentation — expansion pending.

## Guidance for Use

### Intended Setting

Oncology and chronic disease services, survivorship programs, palliative care, and primary care in low-resource-first deployment, with collection channels (SMS, voice, caregiver-assisted) matched to the population's actual connectivity. The module is intended for clinical human-good applications; consistent with the Tier II architecture, it is specified for degraded-infrastructure operation, with offline synchronization, battery operation, SMS fallback, and low-bandwidth mode where power or connectivity is unstable.

### Prerequisites

- Instrument licensing and language validation confirmed for the selected PRO measures; escalation pathway staffed for severe symptom and suicidal ideation triggers before remote monitoring is activated.
- Supervision by licensed clinicians who retain final authority for every patient decision; the module is a governance layer, not an autonomous practitioner.
- Local validation of all thresholds and pathways against jurisdictional guidelines, formulary, and scope-of-practice rules before any clinical use.
- An accountability chain (verification, documentation, ownership, follow-up, escalation) as required by the shared CLAI-OS closed-loop methodology.
- For integrated deployments: HL7 FHIR R4-compatible infrastructure; the architecture is specified to degrade gracefully (offline synchronization, battery operation, SMS fallback, low-bandwidth mode) where infrastructure is unstable.

### Misuse

- Do not use quality-adjusted survival outputs to rank the worth of patients' lives or to deny treatment; the design uses them to align therapy with patient-prioritized outcomes.
- Do not present module output as a clinical diagnosis, prescription, or substitute for professional judgment.
- Do not use to deny, delay, or ration care on the basis of race, disability, wealth, insurance status, or any protected characteristic; the design explicitly prohibits such inputs.
- Do not attempt to reconstruct or reimplement the withheld prompt body from this document; the abstract and methodology are published for examination and validation, not for unsupervised clinical deployment.
- Do not deploy as an autonomous system that overrides documented patient wishes, assigns futility, initiates withdrawal of care, or delays emergent intervention; the architecture carries hard-stops against each of these.

---

C0 informational classification; confers no clinical, legal, financial, or safety authority.
